| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on June 30, 2009
From the National Stroke Research Institute (G.A.D.), Melbourne, Australia; and Royal Melbourne Hospital (S.M.D.), Parkville, Victoria, Australia. * To whom correspondence should be addressed. E-mail: stephen.davis{at}mh.org.au.
Accepted on June 30, 2009
Angiotensin Receptor Blockers and Stroke Therapy. It Is All About the Blood Pressure
Geoffrey A. Donnan MD, FRACP and Stephen M. Davis MD, FRACP*
Key words: controversy
prevention
risk factors
|
Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2009 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |